Sequence-dependent toxicity profile in modified FAMTX (fluorouracil-adriamycin-methotrexate) chemotherapy with lenograstim support for advanced gastric cancer: A feasibility study

A. M. Westermann, B. G. Taal, M. Swart, H. Boot, M. Craanen, W. R. Gerritsen

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Sequence-dependent toxicity profile in modified FAMTX (fluorouracil-adriamycin-methotrexate) chemotherapy with lenograstim support for advanced gastric cancer: A feasibility study'. Together they form a unique fingerprint.

Medicine & Life Sciences